Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Schwartzberg

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxisLee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, et al.
The Oncologist|May 8, 2013
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reportingScott D Ramsey, Sean D Sullivan, Shelby D Reed, et al.
Plos One|December 21, 2022
Impact of early detection on cancer curability: A modified Delphi panel studyLee Schwartzberg, Michael S Broder, Sikander Ailawadhi, et al.
Proceedings (Baylor University. Medical Center)|July 18, 2020
Usefulness of patient-reported outcomes to assess the effectiveness of topical hormonal therapy for gynecologic symptoms after antihormonal treatment for breast cancerAmit L Jain, Omer Jamy, Janice Mullins, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancerJoyce O'Shaughnessy, Lee Schwartzberg, Michael A Danso, et al.
JAMA Oncology|June 14, 2019
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Sara M Tolaney, Lee Schwartzberg, et al.
NPJ Breast Cancer|January 31, 2024
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi techniqueEmily J Gallagher, Heather Moore, Mario E Lacouture, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2025
Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial IntelligenceAmir Momen-Roknabadi, Mehran Karimzadeh, Nae-Chyun Chen, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxisLee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, et al.
The Oncologist|May 8, 2013
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reportingScott D Ramsey, Sean D Sullivan, Shelby D Reed, et al.
Plos One|December 21, 2022
Impact of early detection on cancer curability: A modified Delphi panel studyLee Schwartzberg, Michael S Broder, Sikander Ailawadhi, et al.
Proceedings (Baylor University. Medical Center)|July 18, 2020
Usefulness of patient-reported outcomes to assess the effectiveness of topical hormonal therapy for gynecologic symptoms after antihormonal treatment for breast cancerAmit L Jain, Omer Jamy, Janice Mullins, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancerJoyce O'Shaughnessy, Lee Schwartzberg, Michael A Danso, et al.
JAMA Oncology|June 14, 2019
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Sara M Tolaney, Lee Schwartzberg, et al.
NPJ Breast Cancer|January 31, 2024
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi techniqueEmily J Gallagher, Heather Moore, Mario E Lacouture, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2025
Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial IntelligenceAmir Momen-Roknabadi, Mehran Karimzadeh, Nae-Chyun Chen, et al.
Pageof 12